Glassman Wealth Services Agios Pharmaceuticals, Inc. Transaction History

Glassman Wealth Services

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Aug 23, 2022	BUY	$26.68 - $34.81 $2,668 - $3,481	100 New	100 $3,000
Q3 2021 Nov 10, 2021	SELL	$41.92 - $58.18 $3,185 - $4,421	-76 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$52.06 - $61.27 $3,956 - $4,656	76 New	76 $4,000
Q3 2020 Nov 09, 2020	SELL	$33.87 - $55.93 $1,659 - $2,740	-49 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$34.45 - $53.48 $1,688 - $2,620	49 New	49 $3,000
Q1 2020 May 12, 2020	SELL	$31.52 - $53.81 $441 - $753	-14 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$30.08 - $50.59 $210 - $354	7 Added 100.0%	14 $1,000
Q3 2019 Nov 01, 2019	SELL	$32.4 - $49.58 $680 - $1,041	-21 Reduced 75.0%	7 $0
Q2 2019 Aug 08, 2019	BUY	$46.17 - $68.1 $877 - $1,293	19 Added 211.11%	28 $1,000
Q1 2019 May 10, 2019	BUY	$45.92 - $67.67 $413 - $609	9 New	9 $1,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.